Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
[procollagen]-L-lysine + 2-oxoglutarate + O2 | Homo sapiens | - |
[procollagen]-(2S,5R)-5-hydroxy-L-lysine + succinate + CO2 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O00469 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
[procollagen]-L-lysine + 2-oxoglutarate + O2 | - |
Homo sapiens | [procollagen]-(2S,5R)-5-hydroxy-L-lysine + succinate + CO2 | - |
? |
Subunits | Comment | Organism |
---|---|---|
homodimer | in order to be active the ezyme (LH2) needs to form homodimers | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
LH2 | - |
Homo sapiens |
lysyl hydroxylase 2 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
drug target | normalizing the cross-link pattern by selectively inhibiting LH2 (and thus hydroxy-alpha-aminoadipic acid-delta-semialdehyde cross-linking) alters the balance of collagen degradation. It is expected that this results in reversible fibrosis. Since the up-regulation of LH2 is seen in all organs, a drug that specifically inhibits LH2 activity can be used in a wide range of fibrotic disorders. Since LH2 catalyzes only a single reaction downstream in the fibrogenic cascade (namely the formation of unwanted cross-links in collagen of the fibrotic lesions), little (if any) side-effects are expected, as the deposited collagen in the wound area is expected to be normally modified, and thus have the properties (e.g. with respect to tensile strength) required for a normal function of the repaired tissue | Homo sapiens |
physiological function | lysyl hydroxylase 2 is responsible for the formation of telopeptidyl hydroxylysine, leading to the formation of hydroxy-alpha-aminoadipic acid-delta-semialdehyde cross-links by lysyl oxidases. The enzyme is universally up-regulated in fibrosis | Homo sapiens |